Beat Gloor

Bern, BE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 91 publications

Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.

Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.

Journal: Cell reports

Published: May 19, 2026

ASO Visual Abstract: Initiation and Completion of Adjuvant Chemotherapy After Total versus Partial Pancreaticoduodenectomy for Pancreatic Cancer.

ASO Visual Abstract: Initiation and Completion of Adjuvant Chemotherapy After Total versus Partial Pancreaticoduodenectomy for Pancreatic Cancer.

Journal: Annals of surgical oncology

Published: November 04, 2025

Initiation and Completion of Adjuvant Chemotherapy After Total Versus Partial Pancreaticoduodenectomy for Pancreatic Cancer.

Initiation and Completion of Adjuvant Chemotherapy After Total Versus Partial Pancreaticoduodenectomy for Pancreatic Cancer.

Journal: Annals of surgical oncology

Published: September 02, 2025

RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged Survival in Pancreatic Adenocarcinoma.

RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged Survival in Pancreatic Adenocarcinoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: July 29, 2025

Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.

Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.

Journal: Cell reports

Published: May 19, 2025

International validation of the distal pancreatectomy fistula risk score: evaluation in minimally invasive and open surgery.

International validation of the distal pancreatectomy fistula risk score: evaluation in minimally invasive and open surgery.

Journal: Surgical endoscopy

Published: May 12, 2025

Spatially resolved analysis of TGF/BMP signalling in pancreatic ductal adenocarcinoma by digital pathology identifies patient subgroups with adverse outcome.

Spatially resolved analysis of TGF/BMP signalling in pancreatic ductal adenocarcinoma by digital pathology identifies patient subgroups with adverse outcome.

Journal: BMC cancer

Published: April 22, 2025

Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.

Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.

Journal: British journal of cancer

Published: February 13, 2025

Impact of Routine and Selective Preoperative Endoscopic Retrograde Cholangiopancreatography with Stent Placement on Postoperative and Oncologic Outcomes Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma.

Impact of Routine and Selective Preoperative Endoscopic Retrograde Cholangiopancreatography with Stent Placement on Postoperative and Oncologic Outcomes Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma.

Journal: Biomedicines

Published: December 27, 2024

Computer-Aided Diagnostics Helps Accurately Determine Different Expression Levels of Claudin-18.2 in Gastric Cancer.

Computer-Aided Diagnostics Helps Accurately Determine Different Expression Levels of Claudin-18.2 in Gastric Cancer.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: November 29, 2024

Perioperative Fully Closed-loop Versus Usual Care Glucose Management in Adults Undergoing Major Abdominal Surgery: A Two-centre Randomized Controlled Trial.

Perioperative Fully Closed-loop Versus Usual Care Glucose Management in Adults Undergoing Major Abdominal Surgery: A Two-centre Randomized Controlled Trial.

Journal: Annals of surgery

Published: September 30, 2024

Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes in Pancreatic Cancer.

Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes in Pancreatic Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 02, 2024

Showing 1-12 of 91

Last Updated: 09/26/2026